Biomea Fusion, Inc

BMEANASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

72.5M

on 2026-06-30, from 35.9M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

$300.0M

S-3 of 2025-08-05. 1 prospectus supplement filed under it since. S-3 ↗

$100.0M

Biomea Fusion, agreement of 2022-11-25. No at-the-market sales statement read from a 10-Q or 10-K. S-3 ↗

Warrants

37.02M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

3 quarters

$34.8M on 2026-06-30 ÷ $11.8M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-10-06	Public offering incl. 1.00M pre-funded, with warrants at $2.50	12,195,121	$2.05	$25.0M	424B5 ↗
2025-06-17	Public offering incl. 0.55M pre-funded, with warrants at $2.50	20,000,000	$2.00	$40.0M	424B5 ↗